SALBUTAMOL IN THE MANAGEMENT OF WHEEZING IN CHILDREN Federico Marchetti, Laura Badina, Luca Pierantoni Medico E Bambino, 2026 Wheezing is a frequent respiratory condition in early childhood that affects up to one third of children in the first three years of life and represents a common cause of primary care visits, Emergency Unit access and hospital admission. In Italy, the 2014 AIFA regulatory note introduced major restrictions on the use of inhaled salbutamol in children younger than 2 years, by limiting administration to pressurised metered-dose inhalers (MDI) with spacer and recommending lower doses than those suggested by the international guidelines, without differentiating between care settings or disease severity. This precautionary approach, based on limited and heterogeneous evidence, has generated an ongoing debate within the paediatric community. Evidence suggests that short-acting β2-agonists (SABA) may be effective in selected cases of acute bronchospasm in infants and young children, particularly in wheezing phenotypes suggestive of reversible airway obstruction. They are not indicated for isolated cough or viral upper respiratory infections, and are not recommended in bronchiolitis according to the international guidelines. Since 2024, shortages of salbutamol MDI in Italy and across Europe have further complicated this scenario and increased the risk of undertreatment. Recent evidence, including a meta-analysis of randomised controlled trials, supports the short-term safety of inhaled salbutamol in children under 2 years with acute wheezing, with no increase in serious adverse events and a more favourable safety profile with MDI compared with nebulisation. Overall, the current framework highlights a gap between regulatory constraints, clinical evidence, real-world practice and drug availability, and underscores the need for an evidence-based revision of existing recommendations.
Skin of Color in Pediatric Dermatology: A Cross-Sectional Retrospective Analysis Addressing Inclusive Diagnosis and Care Arianna Dondi, Alice Ranieri, Laura Andreozzi, Miriam Leuzzi, Gabriele D’Alanno, Luca Pierantoni, Daniele Zama, Eleonora Battelli, Roberta Calegari, Andrea Borghesi, Marcello Lanari, Iria Neri Life, 2026 Children with skin color (SOC) are underrepresented in dermatologic research, despite structural and functional differences that shape disease presentation. Atopic dermatitis (AD), one of the most common pediatric dermatoses, often appears differently in SOC than in white children. This study compared dermatologic conditions prompting Pediatric Emergency Department (PED) referral in SOC and white children, and described clinical features of AD in SOC. A retrospective study was performed at IRCCS AOUBO Policlinico di Sant’Orsola, Bologna, Italy, analyzing records and photographs from 2019. Patients presenting with dermatologic conditions and evaluated by a pediatric dermatologist were included. Of 411 patients, 109 (26.5%) had SOC. In SOC, common diagnoses were scabies (22%), AD (17.4%), viral infections (12.8%), burns (9.2%), and contact dermatitis (7.3%). In white children, viral infections (16.9%), burns (14.2%), contact dermatitis (13.9%), AD (12.9%), and insect bites (5.6%) predominated. Scabies and pruritus were significantly more frequent in SOC (p < 0.05). Among 38 SOC patients with AD, lichenoid (31.6%), pityriasis alba (29.0%), prurigo nodularis (26.3%), and classic AD (13.2%) were the most frequent variants. Erythema was often subtle or absent. Dermatologic conditions and AD morphology differ between SOC and white children, highlighting the need for tailored diagnostic approaches and equitable care.
The Use of Point-of-Care Tests and Multiplex PCR Tests in the Pediatric Emergency Department Reduces Antibiotic Prescription in Patients with Febrile Acute Respiratory Infections Luca Pierantoni, Arianna Dondi, Liliana Gabrielli, Valentina Lasala, Laura Andreozzi, Laura Bruni, Fiorentina Guida, Eleonora Battelli, Giulia Piccirilli, Ilaria Corsini, Tiziana Lazzarotto, Marcello Lanari, Daniele Zama Pathogens, 2025 Background: Acute Respiratory Infections are a common reason for Pediatric Emergency Department (PED) visits. Differentiating bacterial and viral infections may be challenging and might result in incorrect antibiotic prescriptions and exacerbation of antimicrobial resistance. This study evaluated the impact of new diagnostic tests in PED. Methods: A retrospective cohort of 4882 acute febrile respiratory infection cases presenting to the PED was analyzed, comparing two periods: Period 1 (October 2016–March 2017, n = 2181) and Period 2 (October 2023–March 2024, n = 2701). During Period 1, Group A Streptococcus and Respiratory Syncytial Virus rapid antigen detection tests were available. During Period 2, new point-of-care tests (POCTs), including rapid C-reactive protein and rapid antigen detection for Influenza A, Influenza B, and SARS-CoV-2, and a multiplex PCR nasal swab, were introduced. Results: In Period 2, antibiotic prescriptions decreased by 28.4%, along with a reduction in broad-spectrum antibiotic use. A significant correlation was observed between reduced antibiotic prescription and the use of new POCTs and multiplex PCR tests. Performance of blood tests and chest radiographs also decreased. Conclusions: Implementing novel diagnostic tests in PED helps clinicians select more appropriate management options with an impact on reduced stress and radiation exposure and antibiotic prescription.
Burden and Clinical Characteristics of Influenza and Its Complications in Children Across Multiple Epidemic Seasons Arianna Dondi, Fiorentina Guida, Ludovica Trombetta, Maddalena De Peppo Cocco, Giulia Piccirilli, Laura Andreozzi, Eleonora Battelli, Pasquale Castaldo, Ilaria Corsini, Luca Pierantoni, Martina Franceschiello, Liliana Gabrielli, Monia Gennari, Dalila Periccioli, Tiziana Lazzarotto, Daniele Zama, Marcello Lanari Viruses, 2025 Seasonal influenza is a major cause of morbidity and hospitalization in children, with the potential for severe complications and considerable socioeconomic impact. We conducted a retrospective observational study including 1046 children aged 0–14 years with laboratory-confirmed influenza who accessed the Paediatric Emergency Department of a tertiary center in Bologna, Italy, across three consecutive epidemic seasons (2022–2025). While the entire cohort was analysed, particular attention was given to children with severe complications requiring hospitalization, for whom more detailed clinical and laboratory data were available. Overall, 12.3% of patients required hospitalization, and 6.1% experienced complications, most frequently influenza-associated encephalopathy, lower respiratory tract infections and myositis. Influenza A predominated overall (82.0%), except for in the last season, which saw a predominance of influenza B (57.4%), closely associated with myositis and elevated creatine phosphokinase levels. Younger age was consistently associated with increased severity and hospitalization. Intensive care admissions were rare (0.8%), and no deaths were recorded. Our findings suggest that, although influenza is generally self-limiting, younger children are at higher risk of complications. These results highlight the importance of active surveillance, careful monitoring of clinical manifestations and targeted paediatric vaccination strategies to reduce the burden of seasonal influenza.
High Flow Nasal Cannula and Non Invasive Ventilation for Acute Bronchiolitis in the Paediatric Wards Luca Pierantoni, Giacomo Stera, Carlotta Biagi, Arianna Dondi, Lawrence M. Scheier, Marcello Lanari Acta Paediatrica International Journal of Paediatrics, 2025 AimBronchiolitis is a leading cause of respiratory distress and hospital admissions in infants. While high‐flow nasal cannula is effective for patients unresponsive to standard oxygen therapy, evidence regarding continuous positive airway pressure and noninvasive ventilation in the wards remains inconclusive. This review explores the feasibility and criteria for initiation, titration, and monitoring of high‐flow nasal cannula, continuous positive airway pressure, and noninvasive ventilation in infants with bronchiolitis in paediatric wards.MethodsNarrative review of studies from PubMed and the Cochrane Library (2000–2024), focusing on high‐flow nasal cannula, continuous positive airway pressure, and noninvasive ventilation in bronchiolitis, particularly in paediatric wards.ResultsHigh‐flow nasal cannula is widely used in paediatric wards as a safe and effective option for bronchiolitis. Evidence for continuous positive airway pressure and noninvasive ventilation outside intensive care is limited but suggests potential to reduce escalation in selected cases.ConclusionContinuous positive airway pressure and noninvasive ventilation in paediatric wards appear to carry limited safety concerns. While not proven superior to high‐flow nasal cannula or standardised in their use, when applied selectively with trained staff and close monitoring, they may serve as rescue therapies. Better understanding of current evidence may support standardisation and improve resource allocation.
Salbutamol safety in children under 2 years of age with acute wheezing: a meta-analysis of randomised controlled trials Luca Pierantoni, Edoardo Muratore, Sara Cerasi, Daniele Zama, Chiara Del Bono, Davide Gori, Riccardo Masetti, Marcello Lanari Archives of Disease in Childhood, 2025 ObjectiveTo evaluate the safety of short-term use of inhaled salbutamol in children under 2 years of age with acute wheezing.Data sourcesElectronic databases (PubMed, Trip, MEDLINE) and the Cochrane Library were searched for studies published up to October 2022.Study selectionThe search was restricted to randomised controlled trials published in English regarding the safety of inhaled salbutamol in wheezing children under the age of 2.Data extraction and synthesisThe literature search strategy yielded 3532 references. The meta-analysis was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines.Main outcome(s) and measure(s)The incidence of adverse reactions associated with inhaled salbutamol administration compared with placebo.ResultsA total of 24 records were included. In 7 studies involving 597 patients, inhaled salbutamol was compared with controls and no statistically significant difference in the incidence of adverse drug reactions was found between the two groups (OR 2.12, 95% CI 0.69 to 6.51; p=0.19). Salbutamol administration via nebulisation was associated with an increased incidence of adverse reactions (OR 6.76, 95% CI 2.01 to 22.71; p=0.002). None of the studies reported severe cardiac side effects that necessitated withdrawal from the study following salbutamol administration. Only one study reported a significant non-cardiac side effect (severe tremulousness) that necessitated withdrawal from therapy.ConclusionsInhaled salbutamol can be safely used in children under 2 years of age with acute wheeze with the administration via a metered-dose inhaler being potentially safer than a nebulised formulation. Neither of the formulations was associated with severe adverse effects.
Addressing Bias and Data Scarcity in AI-Based Skin Disease Diagnosis with Non-Dermoscopic Images Ceur Workshop Proceedings, 2025
Endothelial Dysfunction: Molecular Mechanisms and Therapeutic Strategies in Kawasaki Disease Lucia Paolini, Fiorentina Guida, Antonino Calvaruso, Laura Andreozzi, Luca Pierantoni, Marcello Lanari, Marianna Fabi International Journal of Molecular Sciences, 2024 The endothelium plays a key role in regulating vascular homeostasis by responding to a large spectrum of chemical and physical stimuli. Vasculitis is a group of inflammatory conditions affecting the vascular bed, and it is known that they are strongly linked to endothelial dysfunction (ED). Kawasaki disease (KD) is one childhood systemic vasculitis, and it represents the leading cause of acquired cardiac disease in children due to coronary damage and subsequent cardiovascular (CV) morbidity and mortality. We aimed to focus on the actual knowledge of ED in the pathogenesis of KD and its practical implications on therapeutical strategies to limit cardiovascular complications. Understanding ED in KD provides insight into the underlying mechanisms and identifies potential therapeutic targets to mitigate vascular damage, ultimately improving cardiovascular outcomes in both the acute and chronic stages of the disease. However, research gaps remain, particularly in translating findings from animal models into clinical applications for cardiovascular lesions and related morbidity in KD patients.
Prevalence of and factors associated with Na + /K + imbalances in a population of children hospitalized with febrile urinary tract infection Pierluigi Marzuillo, Stefano Guarino, Luigi Annicchiarico Petruzzelli, Milena Brugnara, Ciro Corrado, Anna Di Sessa, Gabrile Malgieri, Marco Pennesi, Floriana Scozzola, Francesca Taroni, Andrea Pasini, Claudio La Scola, Giovanni Montini, , Mattia Arenella, Salvatore Alfiero, Francesco Baccelli, Giulia Delcaro, Giulia Gallotta, Marcello Lanari, Maya Lorenzi, Emanuele Miraglia del Giudice, Carmine Pecoraro, Sara Picassi, Luca Pierantoni, Chiara Tosolini, Laura Venditto European Journal of Pediatrics, 2024
Treatment of acute pharyngitis in children: an Italian intersociety consensus (SIPPS-SIP-SITIP-FIMP-SIAIP-SIMRI-FIMMG) Elena Chiappini, Giovanni Simeone, Marcello Bergamini, Roberta Pellegrino, Alfredo Guarino, Annamaria Staiano, Susanna Esposito, Guido Castelli Gattinara, Andrea Lo Vecchio, Stefania Stefani, Iride Dello Iacono, Immacolata Scotese, Giovanna Tezza, Giulio Dinardo, Simona Riccio, Sofia Pellizzari, Sonia Iavarone, Giulia Lorenzetti, Elisabetta Venturini, Daniele Donà, Luca Pierantoni, Mattia Doria, Silvia Garazzino, Fabio Midulla, Claudio Cricelli, Luigi Terracciano, Annalisa Capuano, Eugenia Bruzzese, Daniele Ghiglioni, Lara Fusani, Eleonora Fusco, Paolo Biasci, Lamberto Reggiani, Luigi Matera, Enrica Mancino, Elisa Barbieri, Antonio D’Avino, Laura Cursi, Maria Giuseppa Sullo, Silvestro Scotti, Gian Luigi Marseglia, Giuseppe Di Mauro, Nicola Principi, Luisa Galli, Maria Carmen Verga Italian Journal of Pediatrics, 2024
Acute kidney injury in children hospitalised for febrile urinary tract infection Pierluigi Marzuillo, Stefano Guarino, Salvatore Alfiero, Luigi Annicchiarico Petruzzelli, Mattia Arenella, Francesco Baccelli, Milena Brugnara, Ciro Corrado, Giulia Delcaro, Anna Di Sessa, Giulia Gallotta, Marcello Lanari, Maya Lorenzi, Gabriele Malgieri, Emanuele Miraglia del Giudice, Carmine Pecoraro, Marco Pennesi, Sara Picassi, Luca Pierantoni, Giuseppe Puccio, Floriana Scozzola, Francesca Taroni, Chiara Tosolini, Laura Venditto, Andrea Pasini, Claudio La Scola, Giovanni Montini, and Acta Paediatrica International Journal of Paediatrics, 2024
Acute pharyngitis in children and adults: descriptive comparison of current recommendations from national and international guidelines and future perspectives Roberta Pellegrino, Edoardo Timitilli, Maria Carmen Verga, Alfredo Guarino, Iride Dello Iacono, Immacolata Scotese, Giovanna Tezza, Giulio Dinardo, Simona Riccio, Sofia Pellizzari, Sonia Iavarone, Giulia Lorenzetti, Giovanni Simeone, Marcello Bergamini, Daniele Donà, Luca Pierantoni, Silvia Garazzino, Susanna Esposito, Elisabetta Venturini, Guido Castelli Gattinara, Andrea Lo Vecchio, Gian Luigi Marseglia, Giuseppe Di Mauro, Nicola Principi, Luisa Galli, Elena Chiappini, Stefania Stefani, Giulia Brigadoi, Fabio Midulla, Claudio Cricelli, Luigi Terracciano, Annalisa Capuano, Eugenia Bruzzese, Daniele Ghiglioni, Fusani Lara, Eleonora Fusco, Paolo Biasci, Lamberto Reggiani, Mattia Doria, Eugenia Bruzzese, Luigi Matera, Enrica Mancino, Elisa Barbieri, Antonio D’Avino, Laura Cursi, Maria Giuseppa Sullo, Silvestro Scotti, and European Journal of Pediatrics, 2023
Antibiotic Prophylaxis for the Prevention of Urinary Tract Infections in Children: Guideline and Recommendations from the Emilia-Romagna Pediatric Urinary Tract Infections (UTI-Ped-ER) Study Group Giovanni Autore, Luca Bernardi, Filippo Ghidini, Claudio La Scola, Alberto Berardi, Giacomo Biasucci, Federico Marchetti, Andrea Pasini, Maria Elena Capra, Claudia Castellini, Vera Cioni, Sante Cantatore, Andrea Cella, Francesca Cusenza, Alessandro De Fanti, Elisa Della Casa Muttini, Margherita Di Costanzo, Alessandra Dozza, Claudia Gatti, Cristina Malaventura, Luca Pierantoni, Giovanni Parente, Gabriella Pelusi, Serafina Perrone, Laura Serra, Francesco Torcetta, Enrico Valletta, Gianluca Vergine, Francesco Antodaro, Andrea Bergomi, Jennifer Chiarlolanza, Laura Leoni, Franco Mazzini, Roberto Sacchetti, Agnese Suppiej, Lorenzo Iughetti, Andrea Pession, Mario Lima, Susanna Esposito, and Antibiotics, 2023
Eligibility criteria for pediatric patients who may benefit from anti SARS-CoV-2 monoclonal antibody therapy administration: an Italian inter-society consensus statement Marcello Lanari, Elisabetta Venturini, Luca Pierantoni, Giacomo Stera, Guido Castelli Gattinara, Susanna Maria Roberta Esposito, Silvia Favilli, Emilio Franzoni, Eleonora Fusco, Paolo Lionetti, Claudio Maffeis, Gianluigi Marseglia, Laura Massella, Fabio Midulla, Alberto Zanobini, Marco Zecca, Alberto Villani, Annamaria Staiano, Luisa Galli, Francesco Blasi, Angelo Di Giorgio, Daniele Donà, Amelia Licari, Massimo Martinelli, Antonio Mastrangelo, Michele Miraglia del Giudice, Giangiacomo Nicolini, Fabrizio Pugliese, Pasquale Striano, Giuliana Valerio, and Italian Journal of Pediatrics, 2022
COVID-19 in Infants Less than 3 Months: Severe or Not Severe Disease? Daniele Dona’, Carlotta Montagnani, Costanza Di Chiara, Elisabetta Venturini, Luisa Galli, Andrea Lo Vecchio, Marco Denina, Nicole Olivini, Eugenia Bruzzese, Andrea Campana, Roberta Giacchero, Filippo Salvini, Antonella Meini, Matteo Ponzoni, Sandra Trapani, Elena Rossi, Mary Haywood Lombardi, Raffaele Badolato, Luca Pierri, Giulia Pruccoli, Sara Rossin, Claudia Colomba, Salvatore Cazzato, Ilaria Pacati, Giangiacomo Nicolini, Luca Pierantoni, Sonia Bianchini, Andrzej Krzysztofiak, Silvia Garazzino, Carlo Giaquinto, Guido Castelli Gattinara, and Viruses, 2022
Midazolam premedication in ileocolic intussusception: a retrospective multicenter study Martina Giacalone, Luca Pierantoni, Valeria Selvi, Antonino Morabito, Michelangelo Baldazzi, Mario Lima, Marcello Lanari, Stefano Masi, Filippo Incerti, Francesca Fierro, Massimo Basile, Roberto Lo Piccolo, Vincenzo Davide Catania, Irene Bettini, Niccolò Parri European Journal of Pediatrics, 2022
Management of Pediatric Urinary Tract Infections: A Delphi Study Giovanni Autore, Luca Bernardi, Claudio La Scola, Filippo Ghidini, Federico Marchetti, Andrea Pasini, Luca Pierantoni, Claudia Castellini, Claudia Gatti, Cristina Malaventura, Gabriella Pelusi, Francesco Antodaro, Andrea Bergomi, Franco Mazzini, Giovanni Parente, Roberto Pillon, Francesca Cusenza, Giacomo Biasucci, Alessandro De Fanti, Lorenzo Iughetti, Serafina Perrone, Andrea Pession, Mario Lima, Susanna Esposito, and Antibiotics, 2022
A CASE OF CONVULSIONS WITH GASTROENTERITIS Chiara Del Bono, Federica Ciambrelli, Alessandro Rocca, Luca Pierantoni, Monia Gennari, Marcello Lanari Medico E Bambino, 2022
Italian consensus on the therapeutic management of uncomplicated acute hematogenous osteomyelitis in children Andrzej Krzysztofiak, Elena Chiappini, Elisabetta Venturini, Livia Gargiullo, Marco Roversi, Carlotta Montagnani, Elena Bozzola, Sara Chiurchiu, Davide Vecchio, Elio Castagnola, Paolo Tomà, Gian Maria Rossolini, Renato Maria Toniolo, Susanna Esposito, Marco Cirillo, Fabio Cardinale, Andrea Novelli, Giovanni Beltrami, Claudia Tagliabue, Silvio Boero, Daniele Deriu, Sonia Bianchini, Annalisa Grandin, Samantha Bosis, Martina Ciarcià, Daniele Ciofi, Chiara Tersigni, Barbara Bortone, Giulia Trippella, Giangiacomo Nicolini, Andrea Lo Vecchio, Antonietta Giannattasio, Paola Musso, Elena Serrano, Paola Marchisio, Daniele Donà, Silvia Garazzino, Luca Pierantoni, Teresa Mazzone, Paola Bernaschi, Alessandra Ferrari, Guido Castelli Gattinara, Luisa Galli, Alberto Villani Italian Journal of Pediatrics, 2021
Parents' Perspective of Antibiotic Usage in Children: A Nationwide Survey in Italy Luca Pierantoni, Andrea Lo Vecchio, Jacopo Lenzi, Vincenza Corsi, Lara Campana, Gian Luca Trobia, Antonella Amendolea, Benedetta Di Felice, Giovanni Alighieri, Giovanna Carmela Fabrizio, Massimo Bisceglia, Francesco Peia, Federica Chiale, Beatrice Bartolomei, Chiara Siciliano, Caterina Di Battista, Eva Passone, Chiara di Giovanni, Edward Piergentili, Daniele Donà, Danilo Buonsenso Pediatric Infectious Disease Journal, 2021
Epidemiology, Clinical Features and Prognostic Factors of Pediatric SARS-CoV-2 Infection: Results From an Italian Multicenter Study S. Garazzino, A. Lo Vecchio, L. Pierantoni, F. C. Calò Carducci, F. Marchetti, A. Meini, E. Castagnola, G. Vergine, D. Donà, S. Bosis, I. Dodi, E. Venturini, E. Felici, Roberta Giacchero, M. Denina, Luca Pierri, G. Nicolini, C. Montagnani, A. Krzysztofiak, S. Bianchini, C. Marabotto, P. Tovo, Giulia Pruccoli, M. Lanari, A. Villani, G. Castelli Gattinara, Valeria Filippo Maria Giovanni Barba Paolo Paola Carlo Chi Caldarelli Salvini Corsello Del Berlese Agostoni G Frontiers in Pediatrics, 2021
COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study Florian Götzinger, Begoña Santiago-García, Antoni Noguera-Julián, Miguel Lanaspa, Laura Lancella, Francesca I Calò Carducci, Natalia Gabrovska, Svetlana Velizarova, Petra Prunk, Veronika Osterman, Uros Krivec, Andrea Lo Vecchio, Delane Shingadia, Antoni Soriano-Arandes, Susana Melendo, Marcello Lanari, Luca Pierantoni, Noémie Wagner, Arnaud G L'Huillier, Ulrich Heininger, Nicole Ritz, Srini Bandi, Nina Krajcar, Srđan Roglić, Mar Santos, Christelle Christiaens, Marine Creuven, Danilo Buonsenso, Steven B Welch, Matthias Bogyi, Folke Brinkmann, Marc Tebruegge, Jasmin Pfefferle, Angela Zacharasiewicz, Angelika Berger, Roland Berger, Volker Strenger, Daniela S. Kohlfürst, Anna Zschocke, Benoît Bernar, Burkhard Simma, Edda Haberlandt, Christina Thir, Ariane Biebl, Koen Vanden Driessche, Tine Boiy, Daan Van Brusselen, An Bael, Sara Debulpaep, Petra Schelstraete, Ivan Pavic, Ulrikka Nygaard, Jonathan P. Glenthoej, Lise Heilmann Jensen, Ilona Lind, Mihhail Tistsenko, Ülle Uustalu, Laura Buchtala, Stephanie Thee, Robin Kobbe, Cornelius Rau, Nicolaus Schwerk, Michael Barker, Maria Tsolia, Irini Eleftheriou, Patrick Gavin, Oksana Kozdoba, Borbàla Zsigmond, Piero Valentini, Inga Ivaškeviciene, Rimvydas Ivaškevicius, Valentina Vilc, Elisabeth Schölvinck, Astrid Rojahn, Anastasios Smyrnaios, Claus Klingenberg, Isabel Carvalho, Andreia Ribeiro, Anna Starshinova, Ivan Solovic, Lola Falcón, Olaf Neth, Laura Minguell, Matilde Bustillo, Aida M. Gutiérrez-Sánchez, Borja Guarch Ibáñez, Francesc Ripoll, Beatriz Soto, Karsten Kötz, Petra Zimmermann, Hanna Schmid, Franziska Zucol, Anita Niederer, Michael Buettcher, Benhur S. Cetin, Olga Bilogortseva, Vera Chechenyeva, Alicia Demirjian, Fiona Shackley, Lynne McFetridge, Lynne Speirs, Conor Doherty, Laura Jones, Paddy McMaster, Clare Murray, Frances Child, Yvonne Beuvink, Nick Makwana, Elisabeth Whittaker, Amanda Williams, Katy Fidler, Jolanta Bernatoniene, Rinn Song, Zoe Oliver, Andrew Riordan Lancet Child and Adolescent Health, 2020
Multicentre Italian study of SARS-CoV-2 infection in children and adolescents, preliminary data as at 10 April 2020 Silvia Garazzino, Carlotta Montagnani, Daniele Donà, Antonella Meini, Enrico Felici, Gianluca Vergine, Stefania Bernardi, Roberta Giacchero, Andrea Lo Vecchio, Paola Marchisio, Giangiacomo Nicolini, Luca Pierantoni, Ivana Rabbone, Giuseppe Banderali, Marco Denina, Elisabetta Venturini, Andrzej Krzysztofiak, Raffaele Badolato, Sonia Bianchini, Luisa Galli, Alberto Villani, Guido Castelli-Gattinara, and Eurosurveillance, 2020
THE MANAGEMENT AND TREATMENT OF ACUTE BRONCHIOLITIS IN INFANTS Encyclopedia of Virology New Research Volume 6 6 Volume Set, 2020
THE PREVENTION OF THE RESPIRATORY SYNCYTIAL VIRUS INFECTION IN INFANTS Encyclopedia of Virology New Research Volume 6 6 Volume Set, 2020
Gastrointestinal presentation of kawasaki disease: A red flag for severe disease? Marianna Fabi, Elena Corinaldesi, Luca Pierantoni, Elisa Mazzoni, Chiara Landini, Barbara Bigucci, Gina Ancora, Laura Malaigia, Tetyana Bodnar, Giorgia Di Fazzio, Francesca Lami, Enrico Valletta, Cristina Cicero, Giacomo Biasucci, Lorenzo Iughetti, Federico Marchetti, Paola Sogno Valin, Sergio Amarri, Sandra Brusa, Monica Sprocati, Giuseppe Maggiore, Ada Dormi, Paolo Lanzoni, Andrea Donti, Marcello Lanari Plos One, 2018
Analgesic and sedative drugs in newborns requiring respiratory support. Journal of Maternal Fetal Neonatal Medicine the Official Journal of the European Association of Perinatal Medicine the Federation of Asia and Oceania Perinatal Societies the International Society of Perinatal Obstetricians, 2012
